PATENT CLAIM ANALYSIS

Application Number: 16135540
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["435", "235100"]

Abstract:
The invention provides a targeted bacteriophage-polymer complex comprising a recombinant targeted-bacteriophage and a cationic polymer. The complex has a net positive charge. The invention provides methods of preparing bacteriophages and complexes thereof, and to their uses for the delivery of transgenes in a variety of gene therapy applications.

Claim (Index 40):
The method of  claim 34 , wherein the complex comprises a weight:weight ratio of about 130 ng-320 ng polymer:1 \u03bcg phage.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 97.0
- Lexical Diversity: 1.40541
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13403765', '12714147', '10530168', '14223944', '15380734']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6225733902336247
- 35 USC 102 Novelty (BERT): 0.5245165932067656
- Combined Prediction Score: 0.6127677105309387
- Mean Citation Score: 247.124258
- Max Citation Score: 314.16943
- Similarity Product: 173.244392185719

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test